Large pharmaceutical stocks are starting to look interesting again. Evolving drug pipelines, the approval of new treatments and greater confidence in future earnings growth all suggest investors should take another look at the sector. Read our feature in this week's issue of Shares.
Are you one of the lucky National Grid shareholders set to share a £3.2bn special dividend? The cash lands in investors’ accounts on 2 June and we've published a list of ways you might want to reinvest that cash.
This week’s digital magazine also looks at how much dividend growth you can expect from FTSE 100 stocks over the next three years. There is an article on how to find investment trust bargains. Shares also looks at which fund managers are best at communicating to shareholders and why it can pay to read annual reports.
Elsewhere, you can read about Royal Mail, Dixons Carphone and Revolution Bars, among other companies. And the team explain why they are taking profit on two stocks which have delivered approximately 50% ga
